Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

Understanding eosinophilic esophagitis (EoE)

EoE is a chronic, progressive, inflammatory disease with rising prevalence among children and adults 1-3

  • Approximately 1 in 4000 people have EoE worldwide4
  • Misdiagnosis or underdiagnosis can cause delays of up to 10 years2
  • Behavior modification
  • can mask symptoms and further delay correct diagnosis and treatment2
  • EoE has a High disease burden,causing daily disruptions and restrictions for patients and caregivers1

Dysphagia

Characterized by discomfort during meals due to difficulty swallowing and the need to frequently intake fluids while eating

Chest pain (noncardiac)

Presents in the majority of patients with eosinophilic esophagitis

Fibrostenosis of the esophagus

Fibrosis gradually leads to stenosis (narrowing) in many patients with eosinophilic esophagitis

Food impaction and bolus removal

Food impaction is a direct consequence of esophageal fibrosis and tissue remodeling. Removal of food bolus impaction frequently involves an urgent endoscopic intervention

Impaired quality of life

Frequent vomiting, restricted diets, social isolation and rejection, fatigue, increased emergency room visits, and higher economic burden

Eosinophilic esophagitis is a chronic, progressive, inflammatory disease, characterized by endoscopic and histologic changes to the esophagus1,4

Progressive remodeling and fibrosis may lead to esophageal strictures, which worsen dysphagia and may result in food impaction and require dilation1,4

Despite current management strategies, many patients continue to have active EoE symptoms9,10

There remains an unmet need to reduce esophageal dysfunction and eosinophil-predominant inflammation in order to improve endoscopic signs, clinical symptoms, and quality of life in patients with EoE

While successful for some patients, current standard of care9,10:

  • Leaves many patients symptomatic, with no long-term treatment options
  • Does not fully address type 2 inflammation — the underlying cause of EoE
  • Does not always address symptoms, histology, and endoscopic findings
  • Fails to consider the everyday challenges faced by patients and caregivers